? BIOMEDICAL RESEARCH SUPPORT SHARED RESOURCE New Cancer Center Support Grant Shared Resource The Biomedical Research Support Shared Resource (BRSSR) enables Cancer Center members to perform human subject research in the context of partnerships between Wistar investigators and clinical care providers. Introduced as a developmental core at the 2013 Cancer Center Support Grant (CCSG) renewal, the BRSSR has been launched as a full-service Cancer Center Shared Resource during the last CCSG budget cycle. By providing a centralized resource for human subject-based research at Wistar, the BRSSR makes available to Cancer Center investigators a comprehensive menu of services to (i) coordinate the procurement of human subject-derived biospecimens from clinical partners, volunteers (phlebotomy service) or commercial partners; (ii) provide expertise in fulfilling research compliance with ethical and regulatory mandates; (iii) assist investigators to ensure that biospecimen and data collection is conducted in compliance with Good Clinical Practice (GCP), regulatory mandates (e.g. 21 CFR Part 11, HIPAA etc.) and contractual obligations; (iv) provide access to tissue processing and advanced histotechnology techniques for specimens analysis; and (v) provide low-cost, customized solutions for centralized data storage and management that ensure the consistency, completeness and quality of the data received from clinical providers. Our collaborative partnership with the Helen F. Graham Cancer Center (HFGCC) at Christiana Care Health System (CCHS), a member Institution of the National Community Cancer Center Program (NCCCP), provides Wistar Cancer Center members with access to fresh biospecimens, including fine-needle aspirate, biopsies, surgical resections, and biological fluids from cancer patients, instrumental to fulfill the mission of the Cancer Center in translational and patient-focused cancer research. Substantial institutional investments have been made to develop and validate an electronic data management platform, CDETweb Toolbox, to manage human subject data in the BRSSR. As fully deployed, the CDETweb platform is customizable to meet specific data collection and sample tracking needs, supporting multiple data entry modes (e.g. keying and direct uploads), randomization, asymmetrical visit schedules, screening and entry criteria gatekeeping, and other custom-defined requirements. BRSSR services also support a phlebotomy service (protocol management, donor management, testing, etc.) and access to tissue microarray services (array design and customization, ordering and tracking). As a result, the BRSSR provides a robust infrastructure to support mechanistic, patient-oriented research by managing all aspects of procurement of human subject-derived biospecimens.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA010815-52
Application #
10145609
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-04-01
Project End
2024-02-29
Budget Start
2021-03-01
Budget End
2022-02-28
Support Year
52
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Wistar Institute
Department
Type
DUNS #
075524595
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Abdel-Mohsen, Mohamed; Kuri-Cervantes, Leticia; Grau-Exposito, Judith et al. (2018) CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. Sci Transl Med 10:
Fukumoto, Takeshi; Magno, Elizabeth; Zhang, Rugang (2018) SWI/SNF Complexes in Ovarian Cancer: Mechanistic Insights and Therapeutic Implications. Mol Cancer Res 16:1819-1825
Cañadas, Israel; Thummalapalli, Rohit; Kim, Jong Wook et al. (2018) Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses. Nat Med 24:1143-1150
Basu, Subhasree; Gnanapradeepan, Keerthana; Barnoud, Thibaut et al. (2018) Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1?. Genes Dev 32:230-243
Perales-Puchalt, Alfredo; Perez-Sanz, Jairo; Payne, Kyle K et al. (2018) Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapy. J Leukoc Biol 103:799-805
Colón, Krystal; Speicher, David W; Smith, Peter et al. (2018) S100a14 is Increased in Activated Nk Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte-Nk crosstalk. J Acquir Immune Defic Syndr :
Schug, Zachary T (2018) Formaldehyde Detoxification Creates a New Wheel for the Folate-Driven One-Carbon ""Bi""-cycle. Biochemistry 57:889-890
Karakashev, Sergey; Zhu, Hengrui; Wu, Shuai et al. (2018) CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity. Nat Commun 9:631
Jenkins, Russell W; Aref, Amir R; Lizotte, Patrick H et al. (2018) Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids. Cancer Discov 8:196-215
Barnoud, Thibaut; Budina-Kolomets, Anna; Basu, Subhasree et al. (2018) Tailoring Chemotherapy for the African-Centric S47 Variant of TP53. Cancer Res 78:5694-5705

Showing the most recent 10 out of 741 publications